Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn

______________________________________________________________________________________________

Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business.

With more than a century’s worth of experience, Taisho, the largest over-the-counter drugmaker in Japan, was established in 1912. The two companies have an established relationship with Taisho having purchased PT Squibb Indonesia from BMS in 2009.

read more

Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business.